HOME

News


Measurement of exotic surfaces

Complex visual effects, such as pearlescence, translucence, iridescence and glitter, help to sell many products, including cars, cosmetics, pharmaceuticals and military hardware. Such surfaces and coatings may look different depending on illumination or viewing angles, which makes them difficult to measure by traditional characterisation methods. NIST in the USA have introduced a goniospectrometer to measure light reflected from a surface as well as its dependence on the directions of illumination and observation.

The new goniospectrometer will be used both to provide an enhanced calibration service and for research on exotic-looking materials and coatings. laura.ost@nist.gov

NMR helps improve Basque cider

Nuclear magnetic resonance (NMR) has been used by José Ignacio Santos González of the University of the Basque Country to improve the quality of cider. NMR combined with chemometric techniques was used to characterise 27 varieties of cider apples, determining general parameters and acidity and sugar profiles throughout the 2000, 2001 and 2002 seasons. Experimental design and factorial analysis were used to determine the influence of new, alternative production technologies (type of press and the material of the fermentation tank) on the general parameters of glycerol and volatile and acidic compounds of both fermenting apple must and of the cider obtained for it. Once bottled, their progress was monitored over a seven-month period.

The influence of various mixtures of apple varieties on the initial composition of the musts and their evolution during fermentation was also studied. www.sc.ehu.es/rmn

ToF-SIMS-IR

The University of Manchester has been awarded £1.7m to build a new instrument that combines time-of-flight secondary ion mass spectrometry (ToF-SIMS) with infrared spectroscopy, which will open new possibilities in the study of biological, organic and inorganic materials. The capabilities of the instrument, which will be built within two years, will be tested on materials such as prostate cancer tissue and environmental particulate pollutants. Professor John Vickerman, Director of the Surface Analysis Research Centre, said: “By combining this capability with infrared spectroscopy we will be able to get a much fuller picture of the chemistry of the molecules and materials we are studying”.

Synchrotron radiation helps preserve Tudor warship

The Mary Rose was Henry VIII’s principal warship for 35 years until she sank outside Portsmouth, UK, in 1545. In 1982 substantial remains of the hull were raised and are currently undergoing conservation whilst open to the public in Portsmouth dockyard. An international team has been analysing the sulphur and iron composition in the timbers of the Mary Rose to determine the potential threat from these. They used synchrotron X-rays from the Stanford Synchrotron Radiation Laboratory (USA) and the European Synchrotron Radiation Facility (France); results have been published in PNAS. They found that there are about two tons of sulphur in different compounds rather uniformly distributed within the 280ton hull. The sulphur species present in the wood were determined at SSRL and their precise location at the micrometre level at ESRF. By studying thin wood slices cut perpendicularly to the cell walls at X-ray microscopy beamline ID21, they found high concentrations of organo-sulphur compounds in the lignin-rich areas between the cells, which may have helped preserve the ship while it was submerged. This helped to understand how accessible and reactive the different sulphur compounds found are to acid-producing oxidation.

The hull of the Mary Rose
The hull of the Mary Rose. Courtesy of the Mary Rose Trust.

Plenty of iron and pyrite is also present in the Mary Rose, which is a concern, since in the moist wood iron ions can catalyse the conversion of sulphur to sulphuric acid in the presence of oxygen. The investigators suggest that chemical treatments to remove or stabilise the remaining iron and sulphur compounds and reducing humidity and oxygen access are requirements for long-term preservation. www.maryrose.org, dx.doi.org/10.1073/pnas.0504490102

CIDETEC Award

The first CIDETEC award for scientific research has been presented to Professor Antonio Aldaz Riera for his work, “In situ Surface-Enhanced Raman Spectroscopy on Electrodes with Platinum and Palladium Nanoparticle Ensembles”. The award was preented during the XXVII Meeting of the Electrochemical Specialisation Group of the Royal Spanish Chemical Society. www.cidetec.es

Bruker AXS has made two announcements that mark its entry into the X-ray microanalysis market. It is buying two microanalysis businesses. Roentec AG, an X-ray microanalysis instrumentation company with annual revenues of $6–7million, based in Berlin, Germany, is being bought. In addition, Bruker AXS is acquiring the PGT X-ray microanalysis business from Princeton Gamma-Tech Instruments. This business has revenues of $5–6million. Once both transactions have completed, the two businesses will be combined into the new “Bruker AXS Microanalysis Group”. www.bruker-axs.com
GeneBio and Genedata have announced a collaboration that will offer life science researchers a precise, high-throughput solution for analysing proteomics data. The two companies will integrate the Genedata Expressionist solution with the Melanie/ImageMaster 2D Platinum solution. www.genedata.com, www.genebio.com
GeneEd and PerkinElmer have announced a partnership in which PerkinElmer will use GeneEd’s custom eLearning capabilities and will resell eLearning courses globally. A course on atomic absorption is currently available, and ones on ICP and chromatography are planned. www.perkinelmer.com, www.geneed.com
Jeol has announced that they have been awarded a US Patent for the DART (direct analysis in real time) atmospheric pressure ion source for mass spectrometers. www.jeolusa.com
LighTouch Medical have developed a non-invasive blood glucose monitor based on Raman spectroscopy. The monitor has come out of work by Professor Joseph Chaiken of Syracuse University, USA. lightouchmedical.com
Oxford nanoScience has won the Product category of the annual Nano 50 Awards for its 3-dimensional atom probe. The awards recognise the top 50 technologies, products and innovators that have significantly impacted, or are expected to impact, the state of the art in nanotechnology. www.oxfordnanoscience.com
PerkinElmer is continuing to focus on health science and photonics with the sale of its aerospace business and discussions to sell the semiconductor and fluid testing businesses. www.perkinelmer.com
Protein Discovery has launched a mass spectrometry tissue imaging service. The service will provide insights into protein expression, disease progression and drug metabolism for pharmaceutical and biotech organisations. The service is based on proprietary processes and exclusive technology licences from Vanderbilt University and the University of Texas, USA. www.proteindiscovery.com
Thermo Electron has received the 2000th order for its M Series atomic absorption spectrometer. www.thermo.com
Viaspace has announced that its subsidiary, Ionfinity, has issued its fifth patent, “Soft ionization device and applications thereof”, which relates to a wide variety of devices that incorporate Ionfinity’s ionisation source with detectors. www.viaspace.com
Varian has acquired PL International and its subsidiaries, including Polymer Laboratories for approximately $42million in cash. www.varianinc.com
Vitalea Science has announced results of a microdose study using its accelerator mass spectrometry (AMS) technology. The clinical study was performed with azidothymidine (AZT), the first approved antiretroviral for combating HIV. The use of AMS enabled the evaluation of human metabolism of AZT at a dosage far lower than possible with conventional techniques. This approach circumvents years of animal testing. www.vitaleascience.com
Financials
Applied Biosystems’ net revenues for the first quarter of their 2006 fiscal year were $416 million, a 6% increase on the previous year. Net income was $57.5million, $37.1million in the same period in the previous year. www.appliedbiosystems.com
Bio-Rad Laboratories announced third-quarter net sales from continuing operations of $283.2million, up 9.4% on 2004, with net income of $16.2million ($6.3million in 2004). For the first nine months of the financial year, net sales were $873.7million ($782.1million in 2004) and net income $68.1million ($51.1million in 2004). www.bio-rad.com
Bruker BioSciences’ third-quarter 2005 revenues were $70.7million, a 6.4% increase on the third quarter of 2004. Net income was $1.1million, as opposed to a loss of $3.1million in 2004. www.bruker-biosciences.com
Coherent has announced fourth-quarter net sales of $133.8million and net income of $5.3million. 2004 figures were $133.2million and $9.4million, respectively. Figures for the full fiscal year were net sales of $516.3million and net income was $39.9million; $495million and $17.4million in 2004, respectively. www.coherent.com
PerkinElmer has announced third-quarter 2005 revenue of $361.9 million, an increase of 6% over the third quarter of 2004. Net income for the period was $31.8 million, $80.6 in 2004. Sales for the first nine months of 2005 were $1092.3 million, $1028.4 million in the first nine months of 2004. Net income for this period was $80.6 million in 2005 and $58.1 million in 2004. www.perkinelmer.com
Thermo Electron Corporation has seen revenues in their third quarter of 2005 grow 25% to $679 million. Net income was $57.7 million, $106.5 million in the same period in 2004. www.thermo.com
Waters Corporation has third-quarter 2005 sales growth of 3% to $273 million and net income was $25.7 million ($51.9 million for the same period in 2004). Sales for the first nine months were $826 million, a 6% increase on 2004, and net income was $126.4 million ($152.5 million in 2004). www.waters.info
Varian reported fourth-quarter sales of $198.1million, an increase of 6.1%, and net earnings of $14.6million. Sales for the fiscal year were $772.8million ($724.4million in 2004) and net earnings were $12million ($59.5million in 2004). www.varianinc.com